Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-06

Clinical Trial Update: Study of Enzyme Supplements to Treat Celiac Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating enzyme supplements for treating celiac disease (also affecting dermatitis herpetiformis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enzyme Supplement (enzyme supplement)

Snippet

Sponsor: Heim Pal Children's Hospital | Conditions: Celiac Disease, Dermatitis Herpetiformis | Phase 1, Phase 2 | Status: COMPLETED